RhumbLine Advisers
HURA

RhumbLine Advisers’s TuHURA Biosciences HURA Stock Holding History

RhumbLine Advisers’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Sell
6,863
-13,867
-67% -$32.3K ﹤0.01% 3846
2026
Q1 		$37.1K Sell
20,730
-2,868
-12% -$3.52K ﹤0.01% 3643
2025
Q4 		$17.9K Buy
23,598
+1,663
+8% +$3.18K ﹤0.01% 3777
2025
Q3 		$54.4K Sell
21,935
-2,841
-11% -$7.48K ﹤0.01% 3643
2025
Q2 		$55.2K Buy
+24,776
New +$83.7K ﹤0.01% 3656

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

RhumbLine Advisers's HURA Position: Q2 2026 in Review

RhumbLine Advisers reduced its TuHURA Biosciences (HURA) stake by 67% in Q2 2026, selling an estimated $32.3K and leaving 6,863 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3846.

RhumbLine Advisers first reported a position in HURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $55.2K in Q2 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • RhumbLine Advisers held 6,863 shares of TuHURA Biosciences worth $16.1K as of Q2 2026.
  • RhumbLine Advisers sold 13,867 TuHURA Biosciences shares in Q2 2026, an estimated $32.3K.
  • TuHURA Biosciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3846 holding.
  • RhumbLine Advisers first reported a position in TuHURA Biosciences in Q2 2025 and has held it in 5 quarters since.
  • RhumbLine Advisers's TuHURA Biosciences position peaked at $55.2K in Q2 2025.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.